PH-0159: NANORAY-103: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases. (November 2020) - De Baère, T.; Pracht, M.; Rolland, Y.; Durand-Labrunie, J.; Nguyen, F.; Bronowicki, J.; Vendrely, V.; Cunha, A. Sa; Croisé-Laurent, V.; Rio, E.; Le Sourd, S.; Said, P.; et al.